BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 15616252)

  • 1. Diabetic nephropathy: diagnosis, prevention, and treatment.
    Gross JL; de Azevedo MJ; Silveiro SP; Canani LH; Caramori ML; Zelmanovitz T
    Diabetes Care; 2005 Jan; 28(1):164-76. PubMed ID: 15616252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DIABETIC NEPHROPATHY AS A CAUSE OF CHRONIC KIDNEY DISEASE].
    Kos I; Prkačin I
    Acta Med Croatica; 2014 Dec; 68(4-5):375-81. PubMed ID: 26285470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
    Jerums G; MacIsaac RJ
    Treat Endocrinol; 2002; 1(3):163-73. PubMed ID: 15799209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microalbuminuria in diabetes mellitus--illness or symptom?].
    Müller WA
    Versicherungsmedizin; 1996 Jun; 48(3):70-6. PubMed ID: 8737541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic nephropathy.
    Zelmanovitz T; Gerchman F; Balthazar AP; Thomazelli FC; Matos JD; Canani LH
    Diabetol Metab Syndr; 2009 Sep; 1(1):10. PubMed ID: 19825147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
    Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
    Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY; Chen FQ
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetic nephropathy and cardiac disease].
    Gross JL; Silveiro SP; Canani LH; Friedman R; Leitão CB; Azevedo MJ
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):244-56. PubMed ID: 17505631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and therapeutic aspects of diabetic nephropathy.
    Strippoli GF; Di Paolo S; Cincione R; Di Palma AM; Teutonico A; Grandaliano G; Schena FP; Gesualdo L
    J Nephrol; 2003; 16(4):487-99. PubMed ID: 14696750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?
    Herrera-Pombo JL; Aguilar-Diosdado M; Hawkins F; Campos MM; Moreno A; Garcia-Hernandez A; Castro E; García-Doncel LG; Serraclara A; Sánchez-Malo C; Escobar-Jiménez F
    Nephron Clin Pract; 2005; 101(3):c116-21. PubMed ID: 16015000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.
    Ayodele OE; Alebiosu CO; Salako BL
    J Natl Med Assoc; 2004 Nov; 96(11):1445-54. PubMed ID: 15586648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of early nephropathy in diabetic patients.
    Mogensen CE
    Annu Rev Med; 1995; 46():79-93. PubMed ID: 7598486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Albuminuria in the diabetic patient: practical management].
    Kistler AD
    Praxis (Bern 1994); 2013 Oct; 102(20):1229-35. PubMed ID: 24088233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.